Corey Montgomery
Associate Professor
Also affiliated: Arkansas Children's Hospital (2010–2023); University of Illinois Urbana-Champaign (1996); University of Arkansas Medical Center (2018); Winthrop Rockefeller Foundation (2012–2015); Orthopedic One (2016); Alcorn State University (2005)
Faculty Researcher
Orthopaedics Surgery, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Dr. Corey Montgomery specializes in the care of bone and soft-tissue cancers in adults and children, serving as one of only two orthopaedic oncologists in Arkansas. He completed his orthopaedic surgical training at the University of Arkansas for Medical Sciences and a fellowship in orthopaedic oncology at the University of Miami/Jackson Memorial Hospital. His research focuses on various aspects of oncology, with recent publications addressing neonatal osteoblastic tumors and the targeting of specific cellular pathways in multiple myeloma.
Dr. Montgomery is an associate professor in the Department of Orthopaedics Surgery at the University of Arkansas for Medical Sciences. He has led numerous research projects, resulting in peer-reviewed publications. His scholarly contributions are reflected in an h-index of 15 and over 940 citations across 55 publications. He actively participates in professional organizations such as the American Academy of Orthopaedic Surgeons and the Musculoskeletal Tumor Society.
Research Overview
Dr. Corey Montgomery is an assistant professor of orthopaedic surgery and an associate scientist at the University of Arkansas Medical Sciences in Little Rock, Arkansas. Dr. Montgomery completed five years of orthopaedic surgical training at the University Arkansas Medical Sciences. He then completed an one-year fellowship at the University of Miami/Jackson Memorial Hospital in orthopaedic oncology. He specializes in the care of cancer involving the bone and soft-tissues in both adults and children. Dr. Montgomery is one of only two orthopaedic oncologist in the state of Arkansas.. Over the years, Dr. Montgomery has been active within the American Academy of Orthopaedic Surgeons, the Musculoskeletal Tumor Society and the Southern Orthopaedic Association. He has also been the principal investigator on several numerous research projects resulting in several peer-reviewed research articles.
Metrics
- h-index: 15
- Publications: 55
- Citations: 949
Selected Publications
-
Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
-
Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
-
Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
-
Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
-
Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
-
Reverse Radial Forearm Osteocutaneous Flap for Reconstruction of Thumb Metacarpal with Staged Interposition Arthroplasty for Treatment of Giant Cell Tumor: A Case Report (2025)
-
Interstitial Brachytherapy for Soft Tissue Sarcomas: Outcomes and Patterns of Failure Patterns from a Single Institution Experience (2025)
-
The Effect of a Flipped Classroom Didactic Curriculum on Orthopaedic In-Training Examination Scores for a Resident Cohort (2024)
-
Forequarter Amputation and Resection of Ribs 1–4 for Chronic Osteomyelitis (2024)
-
Virtual orthopaedic surgery away rotation benefits both the program and applicant: a survey of participants (2022)
-
Metastatic Disease Upper Extremity (2021)
-
Tibial Osteolysis After Long-Term Isolated Polyethylene Patellar Resurfacing (2021)
-
The Distribution of Underrepresented Minorities in U.S. Orthopaedic Surgery Residency Programs (2019)
-
Post-Traumatic Sarcomas: Do They Exist? (2019)
-
Giant Cell Tumor of Bone: Review of Current Literature, Evaluation, and Treatment Options (2018)
Collaboration Network
Top Collaborators
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
- Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells
Similar Researchers
Based on overlapping research topics